ResMed Earnings Analysis: Q2 Recap

The Q2 earnings report for ResMed RMD was released on Thursday, January 30, 2025 at 04:05 PM.

Here's what investors need to know about the latest announcement.

Earnings

ResMed beat estimated earnings by 5.0%, reporting an EPS of $2.43 versus an estimate of $2.31.

Revenue was up $119.00 million from the same period last year.

Past Earnings Performance

During the previous quarter, the company beat on EPS by $0.16, leading to a 7.000000000000001% increase share price change the next day.

Here's a look at ResMed's past performance:

Quarter Q1 2025 Q4 2024 Q3 2024 Q2 2024
EPS Estimate 2.04 2.06 1.91 1.79
EPS Actual 2.20 2.08 2.13 1.88
Revenue Estimate 1.18B 1.19B 1.17B 1.15B
Revenue Actual 1.23B 1.22B 1.20B 1.16B

To track all earnings releases for ResMed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

RMD Logo
RMDResMed Inc
$253.601.40%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
74.21
Growth
69.68
Quality
67.22
Value
22.23
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...